← Back to Clinical Trials
Recruiting NCT03931707

NCT03931707 The China Neonatal Genomes Project

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03931707
Status Recruiting
Phase
Sponsor Children's Hospital of Fudan University
Condition Newborn
Study Type OBSERVATIONAL
Enrollment 100,000 participants
Start Date 2016-08-08
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 28 Days
Study Type OBSERVATIONAL
Interventions
Genomic sequencing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100,000 participants in total. It began in 2016-08-08 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The project will carry out the genetic testing of 100000 neonates in the next 5 years. The aim of the project is to construct the Chinese neonatal genome database, establish the genetic testing standard of neonatal genetic diseases, and promote the industrialization of neonatal genetic disease gene testing, improve the training system for genetic counseling.

Eligibility Criteria

Inclusion Criteria: * 1\. Both parents are of Chinese origin; * 2\. Postnatal age less than 28 days; * 3\. Can be retained to at least 1ml venous blood sample; * 4\. Biological parent or guardian's informed consent. Exclusion Criteria: * 1\. the nationality of one of the parents is not the Han nationality or other national minorities; * 2\. reluctance of parents to use genetic sequencing data for subsequent research; * 3\. parents under 18 years of age or incapacitated for decision-making; * 4\. subjects older than 28 days. * 5\. multiple pregnancies; * 6\. lack of access to biological samples from which DNA can be extracted; * 7\. failure to sign informed consent

Contact & Investigator

Central Contact

Wenhao Zhou

✉ zwhchfu@126.com
Principal Investigator

Wenhao Zhou

STUDY CHAIR

Children's Hospital of Fudan University

Frequently Asked Questions

Who can join the NCT03931707 clinical trial?

This trial is open to participants of all sexes, up to 28 Days, studying Newborn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03931707 currently recruiting?

Yes, NCT03931707 is actively recruiting participants. Contact the research team at zwhchfu@126.com for enrollment information.

Where is the NCT03931707 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT03931707 clinical trial?

NCT03931707 is sponsored by Children's Hospital of Fudan University. The principal investigator is Wenhao Zhou at Children's Hospital of Fudan University. The trial plans to enroll 100,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology